ReviewFrontiers in immunology2023

CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.

Iris Lodewijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.